Abstract
In this issue of Blood, Bartlett et al share their experience with the use of ibrutinib in patients with relapsed or refractory follicular lymphoma (FL).
Original language | English (US) |
---|---|
Pages (from-to) | 156-157 |
Number of pages | 2 |
Journal | Blood |
Volume | 131 |
Issue number | 2 |
DOIs | |
State | Published - Jan 11 2018 |
Externally published | Yes |
ASJC Scopus subject areas
- Biochemistry
- Immunology
- Hematology
- Cell Biology